Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 43

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Nov 21, 2005; 11(43): 6823-6827
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6823

Table 2 Flora of ascites and blood

Data are presented as number and percentage of total. NS: not significant.

Citation: Chen TA, Lo GH, Lai KH, Lin WJ. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroenterol 2005; 11(43): 6823-6827
URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6823.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i43.6823

Chen TA, Lo GH, Lai KH, Lin WJ. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroenterol 2005; 11(43): 6823-6827 [PMID: 16425390 DOI: 10.3748/wjg.v11.i43.6823]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.